Endotracheal Intubation

A strategy of first choice endotracheal intubation for Cardiac Arrest

Montefiore Medical Center, New York, NY
Targeting 2 different conditionsA strategy of first choice endotracheal intubation +1 moreN/ARecruitingLed by Ari Moskowitz, MDResearch Sponsored by Montefiore Medical Center

Study Summary

This trial is testing whether one method of airway management during CPR is better than another.

Eligible Conditions
  • Cardiac Arrest
  • Respiratory Failure

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below
Select...
You require assistance with breathing using a mask or other breathing devices.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~time of hospital discharge
This trial's timeline: 3 weeks for screening, Varies for treatment, and time of hospital discharge for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Alive-and-ventilator free days
Secondary outcome measures
72-hour survival
Chest compression fraction
Modified Rankin Scale
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: First choice supraglottic airway device, Then First choice endotracheal intubationExperimental Treatment2 Interventions
A strategy of 'first choice' supraglottic airway during cardiac arrest. Clinicians can deviate to the airway management approach of their choice if deemed to be in the best interest of the patient. As part of a cluster-randomized design, hospitals (4 in the system) will be assigned to one arm for a month and then cross-over to the other arm.
Group II: First choice endotracheal intubation, Then First choice supraglottic airwayActive Control2 Interventions
A strategy of 'first choice' endotracheal intubation during cardiac arrest. Clinicians can deviate to the airway management approach of their choice if deemed to be in the best interest of the patient. As part of a cluster-randomized design, hospitals (4 in the system) will be assigned to one arm for a month and then cross-over to the other arm.

Find a site

Who is running the clinical trial?

Montefiore Medical CenterLead Sponsor
426 Previous Clinical Trials
568,849 Total Patients Enrolled
Ari Moskowitz, MDPrincipal Investigator
Montefiore Medical Center
1 Previous Clinical Trials
95 Total Patients Enrolled

Media Library

A strategy of first choice endotracheal intubation (Endotracheal Intubation) Clinical Trial Eligibility Overview. Trial Name: NCT05520762 — N/A
Cardiac Arrest Research Study Groups: First choice supraglottic airway device, Then First choice endotracheal intubation, First choice endotracheal intubation, Then First choice supraglottic airway
Cardiac Arrest Clinical Trial 2023: A strategy of first choice endotracheal intubation Highlights & Side Effects. Trial Name: NCT05520762 — N/A
A strategy of first choice endotracheal intubation (Endotracheal Intubation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05520762 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any current opportunities to participate in this clinical trial?

"According to the information available on clinicaltrials.gov, this particular medical study has ceased its recruitment efforts for now. It was initially posted in December of 2022 and underwent its latest update in August of that same year. Nevertheless, there are 241 other trials recruiting at this current moment."

Answered by AI
~707 spots leftby Jan 2027